ramosetron: Clinical Trials

13 trials of ramosetron, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed, 4 unknown, 1 terminated. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Completed 8, Unknown 4, Terminated 1

Follow ramosetron: new trials by email Literature Review of ramosetron trials Research Report on ramosetron

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ramosetron on Late PONV (Postoperative Nausea and Vomiting)
Ramosetron Hydrochloride - Postoperative Nausea and Vomiting, Breast Cancer Female
Phase 4CompletedPusan National University Hospital1442020-12-172022-04-19
Ramosetron OD Tablet and Postdischarge Nausea and Vomiting
Ramosetron - Day Surgery
Phase 4UnknownSeoul National University Hospital1382020-05-122021-12-22
Ramosetron Pre-treatment for PONV and QT Prolongation
Ramosetron - PONV, Prolonged QTc Interval
Phase 4CompletedKonkuk University Medical Center642017-07-012018-03-09
Effect of Ramosetron on Bowel Motility After Gynecological Surgery
Ramosetron, Normal saline - Postoperative Nausea and Vomiting
Phase 4UnknownKyunghee University Medical Center882016-07-012017-01-12
Ramosetron, Aprepitant, and Dexamethasone Versus Palonosetron, Aprepitant, and Dexamethasone
ramosetron, aprepitant, dexamethasone, palonosetron, aprepitant, dexamethasone - Cancer, Tumors
Phase 4CompletedKangdong Sacred Heart Hospital2922015-08-192018-05-11
Post-operative Nausea Vomiting in Laparoscopic Cholecystectomy
ramosetron, ondansetron, dexamethasone - Postoperative Nausea and Vomiting
Phase 4UnknownGovernment Medical College, Haldwani1002015-07-012016-06-17
Comparison of Palonosetron and Ramosetron for Preventing Patient-controlled Analgesia Related Nausea and Vomiting Following Spine Surgery; Association With ABCB1 Polymorphism
Ramosetron, Palonosetron - Postoperative Nausea and Vomiting
Phase 4CompletedYonsei University3002014-09-222017-10-27
Evaluation of Safety and Efficacy of Nasea(R)/Ramosetron Inj. in Patients Undergoing Facial Bone Fracture Operations
Ramosetron - Facial Bones Fracture
Phase 4TerminatedSeoul National University Hospital492011-12-012015-05-08
Effect of Ramosetron on Bowel Motility After Colorectal Resection
Ramosetron - Postoperative Nausea and Vomiting
Phase 4UnknownKyunghee University Medical Center642010-12-012011-09-01
A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients
Ramosetron, Placebo - Irritable Bowel Syndrome
Phase 4CompletedAstellas Pharma Inc2962010-10-012014-10-15
Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee Arthroplasty
Ramosetron - Osteoarthritis, Knee
Phase 4CompletedSeoul National University Hospital1532009-09-012012-06-08
A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome
Ramosetron, Placebo - Irritable Bowel Syndrome
Phase 4CompletedAstellas Pharma Inc982009-06-012015-10-12
Efficacy of Dexamethasone Added to Ramosetron for Preventing Postoperative Nausea and Vomiting in Highly Susceptible Patients Following Spine Surgery
ramosetron with saline, ramosetron with dexamethasone - Nausea, Vomiting
Phase 4CompletedYonsei University942008-01-012012-02-03

Conditions studied

Postoperative Nausea and Vomiting (7)  ·  Vomiting (3)  ·  Colonic Diseases (2)  ·  Diarrhea (2)  ·  Irritable Bowel Syndrome (2)  ·  Nausea (2)  ·  Fractures, Bone (1)  ·  Neoplasms (1)  ·  Osteoarthritis, Knee (1)  ·  Signs and Symptoms, Digestive (1)

Sponsors

Seoul National University Hospital (3)  ·  Astellas Pharma Inc (2)  ·  Kyunghee University Medical Center (2)  ·  Yonsei University (2)  ·  Government Medical College, Haldwani (1)  ·  Kangdong Sacred Heart Hospital (1)  ·  Konkuk University Medical Center (1)  ·  Pusan National University Hospital (1)

Countries

South Korea (9)  ·  Japan (2)  ·  India (1)

Top investigators

Chanyeong Heo, Ph.D. (1)  ·  Hyun-Jung Shin, MD., PhD. (1)  ·  Jin-Hyoung Kang, Ph.D (1)  ·  Jung Hye Kwon, PhD (1)  ·  Ka Young Rhee, MD,PhD (1)  ·  Mi Kyeong Kim (1)  ·  Mi Kyeong Kim, M.D., Ph.D. (1)  ·  T K Kim, MD,PhD (1)

Results publications

PMID 28293280, PMID 28331539, PMID 34614204, PMID 35546414